Towards fast and inexpensive molecular diagnostic: the case of TP53

被引:14
作者
Jiang, TS
Minunni, M
Mascini, M
机构
[1] Univ Florence, Dipartimento Chim, I-50019 Sesto Fiorentino, Italy
[2] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China
关键词
TP53; detection of mutations; biosensor; gene chip;
D O I
10.1016/j.cccn.2004.01.018
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Much research suggests that TP53 mutations have prognostic importance and sometimes are a significant factor in clinical oncology. A considerable effort has been made to develop fast and inexpensive methods for TP53 mutations detection. Methods: On the basis of describing the role of TP53 as tumor suppressor gene and TP53 mutation spectrum, the authors discuss conventional methods and new technologies for TP53 mutations detection. This discussion is supported by more recent publications in the field of both molecular genetics and analysis technologies. Results: Biosensors and gene chips are of considerable recent interest, due to their tremendous promise for obtaining sequence-specific information in a faster, simpler and cheaper manner compared to traditional methods. Conclusions: New methods such as biosensors and gene chips appear promising as analytical methods of detecting mutations. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 60
页数:16
相关论文
共 84 条
[1]   Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].
Aas, T ;
Borresen, AL ;
Geisler, S ;
SmithSorensen, B ;
Johnsen, H ;
Varhaug, JE ;
Akslen, LA ;
Lonning, PE .
NATURE MEDICINE, 1996, 2 (07) :811-814
[2]   Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array [J].
Ahrendt, SA ;
Halachmi, S ;
Chow, JT ;
Wu, L ;
Halachmi, N ;
Yang, SC ;
Wehage, S ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7382-7387
[3]   TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck [J].
Alsner, J ;
Sorensen, SB ;
Overgaard, J .
RADIOTHERAPY AND ONCOLOGY, 2001, 59 (02) :179-185
[4]   Application of an antibody biochip for p53 detection and cancer diagnosis [J].
Askari, M ;
Alarie, JP ;
Moreno-Bondi, M ;
Vo-Dinh, T .
BIOTECHNOLOGY PROGRESS, 2001, 17 (03) :543-552
[5]  
Bennett WP, 1999, J PATHOL, V187, P8, DOI 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO
[6]  
2-Y
[7]   COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY [J].
BERGH, J ;
NORBERG, T ;
SJOGREN, S ;
LINDGREN, A ;
HOLMBERG, L .
NATURE MEDICINE, 1995, 1 (10) :1029-1034
[8]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[9]   TP53 and head and neck neoplasms [J].
Blons, H ;
Laurent-Puig, P .
HUMAN MUTATION, 2003, 21 (03) :252-257
[10]   TP53 and breast cancer [J].
Borresen-Dale, AL .
HUMAN MUTATION, 2003, 21 (03) :292-300